Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience Diabetic retinopathy is one of the leading causes of preventable vision loss worldwide, and one of its most concerning features is that significant damage can occur before a person notices
Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience A diagnosis of optic nerve atrophy changes daily life in ways that go well beyond the clinical details of the condition itself. Patients often find themselves navigating practical adjustments, emotional
Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience This is one of the most direct questions patients ask when researching stem cell treatment for eye conditions, and it deserves an equally direct, evidence-grounded answer rather than a hopeful
Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience Retinitis pigmentosa (RP) and macular degeneration are sometimes confused by patients experiencing early vision changes, partly because both are retinal conditions that cause progressive vision loss. But they affect different
Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience Eye stem cell therapy has moved from an experimental concept to a more established, though still evolving, area of regenerative medicine. For patients researching treatment in 2026, understanding the actual
Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience Patients researching eye stem cell therapy tend to arrive with the same set of practical questions – about success rates, cost, and what a realistic outcome actually looks like. These
Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience Receiving a diagnosis of a rare eye disease – whether retinitis pigmentosa, Stargardt’s disease, LHON, or another inherited retinal condition – often comes with more uncertainty than clarity. Many patients
Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience People diagnosed with retinal conditions such as Retinitis Pigmentosa, Stargardt’s Disease, Rod and Cone Dystrophy, or Age-Related Macular Degeneration often begin looking beyond medical treatment for ways to protect their
Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience For many people living with retinal conditions such as Retinitis Pigmentosa, Stargardt’s Disease, Optic Nerve Atrophy, or Rod and Cone Dystrophy, the decision to explore eye stem cell treatment often
Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience Patients living with retinal conditions like retinitis pigmentosa, Stargardt’s disease, or age-related macular degeneration often ask the same question early on: does diet make a difference? The honest answer is

